Computational Biology Market Outlook:
According to a new report by Expert Market Research titled “Global Computational Biology Market Size, Share, Analysis, Growth, Demand, Forecast 2023-2028″, the global computational biology market was valued at over USD 3.6 billion in 2021. It is projected to expand at a CAGR of 22.7% during the forecast period of 2023-2028 and surpass a valuation of USD 12.1 billion by 2028.
Computational Biology is the use of mathematical, statistical, and computational methods to understand biological systems. The market is expected to be driven by the increasing demand for computational biology in drug discovery, personalized medicine, and other fields. The market is also expected to be driven by the development of advanced technologies and the growing adoption of artificial intelligence and machine learning.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/computational-biology-market/requestsample
Computational Biology Market Drivers:
- Increasing demand for computational biology in drug discovery and personalized medicine
- Growing adoption of artificial intelligence and machine learning in computational biology
- Advancements in technology
Computational Biology Market Restraints:
- High cost of software and hardware
- Lack of skilled professionals
- Data privacy and security concerns
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/computational-biology-market
Computational Biology Market Segmentation:
The global Computational Biology Market is segmented on the basis of tools, applications, and regions.
- Analysis Software and Services
- IT Infrastructure
- Drug Discovery and Development
- Disease Modeling and Simulation
- Cellular and Biological Simulation
- Preclinical Drug Development
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Accelrys Inc.
- Chemical Computing Group Inc.
- Compugen Ltd.
- Genedata AG
- Insilico Biotechnology AG
- International Business Machines Corporation (IBM)
- Schrödinger, Inc.
- Simulation Plus Inc.
- Rhenovia Pharma Ltd.
Q: What is computational biology?
A: Computational Biology is the use of mathematical, statistical, and computational methods to understand biological systems.
Q: What are the market drivers for the Computational Biology Market?
A: The increasing demand for computational biology in drug discovery and personalized medicine, growing adoption of artificial intelligence and machine learning in computational biology, and advancements in technology are the major market drivers.
Q: What are the market restraints for the Computational Biology Market?
A: High cost of software and hardware, lack of skilled professionals, and data privacy and security concerns are the major market restraints.
Q: How is the Computational Biology Market segmented?
A: The global Computational Biology Market is segmented on the basis of tools, applications, and regions.
Q: What are the key applications of Computational Biology?
A: The key applications of Computational Biology are drug discovery and development, disease modeling and simulation, cellular and biological simulation, and preclinical drug development.
Q: Which region is expected to dominate the Computational Biology Market?
A: North America is expected to dominate the Computational Biology Market due to the presence of major market players and increasing investments in research and development.
Q: Who are the key players in the Computational Biology Market?
A: The key players in the Computational Biology Market include Accelrys Inc., Certara, Chemical Computing Group Inc., Compugen Ltd., Genedata AG, Insilico Biotechnology AG, International Business Machines Corporation (IBM), Schrödinger, Inc., Simulation Plus Inc., and Rhenovia Pharma Ltd.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Edward Dugger, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA